Table 3.
Pre-lockdown period |
Lockdown period |
Post-lockdown period |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Characteristics | 2018 N = 960 |
2019 N = 889 |
2020 N = 914 |
Change in the number of patients from the mean in 2018–2019 to 2020 (%) | 2018 N = 650 |
2019 N = 645 |
2020 N = 373 |
Evolution of number of patients from mean 2018–2019 to 2020 (%) | 2018 N = 1247 |
2019 N = 1192 |
2020 N = 1012 |
Change in the number of patients from the mean in 2018–2019 to 2020 (%) |
Main treatment provided during the 3 months after the first attending | P = 0.163 | P = 0.778 | P = 0.334 | |||||||||
Curative surgery | 265 (27.6) | 273 (30.7) | 253 (27.7) | −16 (−5.9%) | 184 (28.3) | 174 (27.0) | 110 (29.5) | −69 (−38,5%) | 365 (29.3) | 346 (29.0) | 264 (26.1) | −91.5 (−25.7%) |
Palliative surgery | 20 (2.1) | 17 (1.9) | 18 (2.0) | −0.5 (−2,7%) | 15 (2.3) | 11 (1.7) | 5 (1.3) | −8 (−61.5%) | 31 (2.5) | 23 (1.9) | 29 (2.9) | 2 (+7,4%) |
Endoscopic treatment | 49 (5.1) | 62 (7.0) | 55 (6.0) | −0.5 (−0.9%) | 54 (8.3) | 61 (9.5) | 26 (7.0) | −31.5 (−54.8%) | 112 (9.0) | 93 (7.8) | 90 (8.9) | −12.5 (−12.2%) |
Interventional radiology | 64 (6.7) | 57 (6.4) | 67 (7.3) | 6.5 (+10,7%) | 44 (6.8) | 43 (6.7) | 29 (7.8) | −14.5 (−33.3%) | 71 (5.7) | 82 (6.9) | 72 (7.1) | −4.5 (−5.9%) |
Chemotherapy/radiotherapy | 271 (28.2) | 229 (25.8) | 242 (26.5) | −8 (−1,6%) | 180 (27.7) | 176 (27.3) | 88 (23.6) | −90 (−50,6%) | 317 (25.4) | 269 (22.6) | 252 (24.9) | −41 (−14.0%) |
Best supportive care only | 121 (12.6) | 85 (9.6) | 83 (9.1) | −20 (−9,7%) | 70 (10.8) | 81 (13.6) | 51 (13.7) | −24.5 (−32.4%) | 137 (11.0) | 159 (13.3) | 120 (11.9) | −28 (−18.9%) |
No treatment recorded in the AP-HP hospital | 170 (17.7) | 166 (18.7) | 196 (21.4) | +28 (+8.3%) | 103 (15.9) | 99 (15.4) | 64 (17.2) | −37 (−36.6%) | 214 (17.2) | 220 (18.5) | 185 (18.3) | −32 (−14.7%) |